| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2004 | EP1436427A2 Methods and compositions to evaluate antibody treatment response |
| 07/14/2004 | EP1436426A2 Methods for detecting genetic haplotypes by interaction with probes |
| 07/14/2004 | EP1436425A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 07/14/2004 | EP1436424A2 Differential tagging of polymers for high resolution linear analysis |
| 07/14/2004 | EP1436423A2 Genetic analysis for stratification of cancer risk |
| 07/14/2004 | EP1436421A2 Methods for detecting ovarian cancer |
| 07/14/2004 | EP1436419A1 Methods for detection of target molecules and molecular interactions |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436417A1 Molecular typing of group b streptococci |
| 07/14/2004 | EP1436415A2 Nucleic acid triplex and quadruplex formation |
| 07/14/2004 | EP1436414A1 DETECTION OF i RPOB /i SEQUENCES OF i MYCOBACTERIUM TUBERCULOSIS /i |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436409A2 Lanthanide binding tags |
| 07/14/2004 | EP1436408A1 A method for identifying effector molecules for gene network integration |
| 07/14/2004 | EP1436406A2 Method of modulating or examining ku70 levels in cells |
| 07/14/2004 | EP1436405A2 Dna purification and recovery from high particulate and solids samples |
| 07/14/2004 | EP1436404A2 Engineered templates and their use in single primer amplification |
| 07/14/2004 | EP1436403A2 Use of the adenoviral e2 late promoter |
| 07/14/2004 | EP1436402A2 Coffee plant with reduced alpha-d-galactosidase activity |
| 07/14/2004 | EP1436401A1 Stem-loop vector system |
| 07/14/2004 | EP1436400A1 Multi-cistronic vectors for gene transfer protocols |
| 07/14/2004 | EP1436399A2 Animal integration vector and methods for its use |
| 07/14/2004 | EP1436398A2 Glucosyltransferases which glucosylate abscisic acid |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436396A2 A human g protein coupled receptor |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436393A2 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436391A2 Low-temperature cycle extension of dna with high priming specificity |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436388A2 Novel human proteases and polynucleotides encoding the same |
| 07/14/2004 | EP1436386A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 07/14/2004 | EP1436385A2 Dna polymerases and mutants thereof |
| 07/14/2004 | EP1436384A2 Mutated abl kinase domains |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436382A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 07/14/2004 | EP1436379A1 Dna fpr expression of alpha i-antitrypsin in methylotropic yeast |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436329A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436326A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436324A1 Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436315A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods |
| 07/14/2004 | EP1436314A2 RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIN D1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) |
| 07/14/2004 | EP1436313A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/14/2004 | EP1436312A2 Antisense modulation of ksr expression |
| 07/14/2004 | EP1436311A2 Antisense oligonucleotides and methods to induce tumor cell death |
| 07/14/2004 | EP1436310A1 Antisense modulation of vascular endothelial growth factor receptor-2 expression |
| 07/14/2004 | EP1436309A2 Bgl3 beta-glucosidase and nucleic acids encoding the same |
| 07/14/2004 | EP1436308A2 Antisense modulation of il-1 receptor-associated kinase-4 expression |
| 07/14/2004 | EP1436307A1 Antisense modulation of nac expression |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436086A2 Device for holding a substance library carrier |
| 07/14/2004 | EP1436058A1 Separation medium, its preparation and its use |
| 07/14/2004 | EP1436056A2 Macroporous gel, its preparation and its use |
| 07/14/2004 | EP1436014A1 Cationic lipids suitable for gene transfer |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436001A1 Chicken anemia virus vaccine from cell line |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1435775A2 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes |
| 07/14/2004 | EP1435774A1 Enhanced resolution of tumor metastasis |
| 07/14/2004 | EP1390544A4 Universal multi-variant detection system |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1337670A4 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies |
| 07/14/2004 | EP1337541A4 Massive parallel method for decoding dna and rna |
| 07/14/2004 | EP1250451A4 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP1220943B1 Cellular test system for investgation of metabolic activity of active forms of cytochrome P450 2D6 |
| 07/14/2004 | EP1133465B1 Amphiphilic polyamine compounds |
| 07/14/2004 | EP1124411A4 New plants formed by microparticle bombardment with uncharacterised dna |
| 07/14/2004 | EP1108009A4 Compositions and methods for producing high-level seed-specific gene expression in corn |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0912725B1 Glycosidase enzymes |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | EP0837943B1 In vivo assays for modulators of sterol biosynthesis |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0792932B1 Coprecipitant and method of extracting nucleic acids |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0732398B1 Novel tyrosine kinase |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | EP0538461B1 Transgenic plants with altered polyol content |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1513058A Secretory streptococcus pneumoniae proteins |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511953A Construction of recombined human lymphotoxin alpha and producing process |
| 07/14/2004 | CN1511952A Recombined glucokinase |
| 07/14/2004 | CN1511951A Method for reducing fruit size in plant |
| 07/14/2004 | CN1511950A Stress inducible promoter obtained from rice |